Loading...

Holly Hamilton, PhD

TitleResearch Fellow
SchoolUCSF School of Medicine
DepartmentPsychiatry
Address
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    New York University, New York, NYB.A.2007Psychology
    University of California, Los Angeles, Los Angeles, CAM.A.2010Clinical Psychology
    University of California, Los Angeles, Los Angeles, CAPh.D.2015Clinical Psychology
    San Francisco VA Health Care System, San Francisco, CA2015Clinical Psychology Internship

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Hamilton HK, Williams TJ, Ventura J, Jasperse LJ, Owens EM, Miller GA, Subotnik KL, Nuechterlein KH, Yee CM. Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia. Am J Psychiatry. 2017 Dec 05; appiajp201716111203. PMID: 29202656.
      View in: PubMed
    2. Hamilton HK, Perez VB, Ford JM, Roach BJ, Jaeger J, Mathalon DH. Mismatch Negativity But Not P300 Is Associated With Functional Disability in Schizophrenia. Schizophr Bull. 2017 Aug 03. PMID: 29036701.
      View in: PubMed
    3. Hamilton HK, D'Souza DC, Ford JM, Roach BJ, Kort NS, Ahn KH, Bhakta S, Ranganathan M, Mathalon DH. Interactive effects of an N-methyl-d-aspartate receptor antagonist and a nicotinic acetylcholine receptor agonist on mismatch negativity: Implications for schizophrenia. Schizophr Res. 2017 Jul 12. PMID: 28711472.
      View in: PubMed
    4. Miller GA, Rockstroh BS, Hamilton HK, Yee CM. Psychophysiology as a core strategy in RDoC. Psychophysiology. 2016 Mar; 53(3):410-4. PMID: 26877134.
      View in: PubMed
    5. Goldstein K, Berlin H, Hamilton H, Mitsis E, McClure M, Savage K, Blair N, Feder M, Siever L, New A, Hazlett E. Cognitive and mood functioning in borderline and schizotypal personality disorders. Psychology. 2016; (7):292-299.
    6. Hamilton H, Sun JC, Green MF, Kee KS, Lee J, Sergi M, Sholty GL, Mathis KI, Jetton C, Williams TJ, Kern R, Horan W, Fiske A, Subotnik KL, Ventura J, Hellemann G, Nuechterlein KH, Yee CM. Social cognition and functional outcome in schizophrenia: The moderating role of cardiac vagal tone. J Abnorm Psychol. 2014 Nov; 123(4):764-70. PMID: 25314266; PMCID: PMC4227946.
    7. Ketay S, Hamilton H, Haas BW, Simeon D. Face processing in depersonalization: an fMRI study of the unfamiliar self. Psychiatry Res. 2014 Apr 30; 222(1-2):107-10. PMID: 24582597.
      View in: PubMed
    8. Amodio DM, Hamilton H. Intergroup anxiety effects on implicit racial evaluation and stereotyping. Emotion. 2012 Dec; 12(6):1273-80. PMID: 22775128.
      View in: PubMed
    9. Simeon D, Bartz J, Hamilton H, Crystal S, Braun A, Ketay S, Hollander E. Oxytocin administration attenuates stress reactivity in borderline personality disorder: a pilot study. Psychoneuroendocrinology. 2011 Oct; 36(9):1418-21. PMID: 21546164.
      View in: PubMed
    10. Bartz J, Simeon D, Hamilton H, Kim S, Crystal S, Braun A, Vicens V, Hollander E. Oxytocin can hinder trust and cooperation in borderline personality disorder. Soc Cogn Affect Neurosci. 2011 Oct; 6(5):556-63. PMID: 21115541; PMCID: PMC3190211.
    11. Goldstein KE, Hazlett EA, Savage KR, Berlin HA, Hamilton H, Zelmanova Y, Look AE, Koenigsberg HW, Mitsis EM, Tang CY, McNamara M, Siever LJ, Cohen BH, New AS. Dorso- and ventro-lateral prefrontal volume and spatial working memory in schizotypal personality disorder. Behav Brain Res. 2011 Apr 15; 218(2):335-40. PMID: 21115066; PMCID: PMC3049905.
    12. Simeon D, Hamilton H . In A Moskowitz, I Shafer, M Dorahy. Psychosis, Trauma, and Dissociation: Emerging Perspectives on Severe Psychopathology. Depersonalisation/derealisation disorder and schizotypal personality disorder. 2009.
    13. Berlin HA, Hamilton H, Hollander E. Experimental therapeutics for refractory obsessive-compulsive disorder: translational approaches and new somatic developments. Mt Sinai J Med. 2008 May-Jun; 75(3):174-203. PMID: 18704978.
      View in: PubMed
    Holly's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP